Navigation Links
Study links enzyme to autistic behaviors
Date:7/23/2014

table, which leads to functional deficits that depend on where in the brain that occurs."

Ethell explained that mutations in FMR1, a gene, have been known for more than a decade to cause FXS, but until now it has been unclear how these mutations cause unstable synapses and characteristic physical features of this disorder. The new findings expand on earlier work by the research group that showed that an MMP-9 inhibitor, minocycline, can reduce behavioral aspects of FXS, which then led to its use to treat FXS.

To further establish a causative role for MMP-9 in the development of FXS-associated features, including autistic behaviors, the authors generated mice that were missing both FMR1 and MMP-9. They found that while mice with a single FMR1 mutation showed autistic behaviors and macroorchidism (abnormally large testes), mice that also lacked MMP-9 showed no autistic behaviors.

"Our work points directly to MMP-9 over-activation as a cause for synaptic irregularities in FXS, with potential implications for other autistic spectrum disorders and perhaps Alzheimer's disease," said Doug Ethell, the head of Molecular Neurobiology at the Western University of Health Sciences, Pomona, Calif., and a coauthor on the study.

The research paper represents many years of bench work and effort by a dedicated team led by the Ethells. The work was primarily done in mice, but human tissue samples were also analyzed, with findings found to be consistent. Specifically, the work involved assessing behaviors, biochemistry, activity and anatomy of synaptic connections in the brain of a mouse model of FXS, as well as the creation of a new mouse line that lacked both the FXS gene and MMP-9.

FXS affects both males and females, with females often having milder symptoms than males. It is estimated that about 1 in 5,000 males are born with the disorder.

The Ethells were joined in the study by UCR's Harpreet Sidhu (first author of the research
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study links enzyme to autistic behaviors
(Date:8/28/2015)... ... August 28, 2015 , ... ... at the Zoo to celebrate children helping children, a thank you to the ... West Ohio have contributed to the United Methodist initiative to end malaria deaths. ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Understanding the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews ... This workshop, chaired by internationally renowned expert Fubin Wu, has been specifically ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... 20 grams of high grade protein with zero fat, carbs, sugar, gluten, lactose ... been named a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , ...
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... ... price on Zoom teeth whitening. For just $199, patients can currently receive a one ... traditional in-office teeth whitening procedures, but it includes a number of unique features that ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... outlines potential pharmaceutical, dietary, surgical, and other approaches ... women in the United States, and examines the ... reduction strategies for women at average risk of ... Among the recommendations: aside from following general dietary ...
... Awareness Month, SACRAMENTO, Calif., Nov. 4 Cancer ... the number one natural cause of death in,geriatric cats ... pet deaths,each year. Some breeds are especially susceptible to ... older cats and dogs, cancer also,is the most treatable ...
... Recurring Diluted FFO Per Share Increases 5.7% ... Share Increases 1.9% ... Nov. 4 Nationwide,Health Properties, Inc. (NYSE: NHP ) today announced results ... 30, 2008., "Our third quarter results continue the positive trends from the ...
... RICHMOND, Va., Nov. 4 Markel Corporation,(NYSE: MKL ... for the quarter,ended September 30, 2008 compared to diluted ... of 2007. Diluted net loss per share was $2.63 ... diluted net income per,share of $31.28 for the same ...
... 4 (Nasdaq: WHRTD ) --,World Heart ... 2008, it had received a NASDAQ Staff Deficiency ... Marketplace Rule 4310(c)(7). This rule,requires the Company to ... continued listing on the NASDAQ Capital Market. For ...
... HiArt treatment system for advanced radiation therapy, announced today that it ... Chengdu Twin Peak Accelerator Technology Inc., based in Chengdu, China. ... ... 2008 -- A linear accelerator (linac) is a key component ...
Cached Medicine News:Health News:Spot the Warning Signs of Cancer in Your Pet 2Health News:NHP Reports Third Quarter 2008 Earnings 2Health News:NHP Reports Third Quarter 2008 Earnings 3Health News:NHP Reports Third Quarter 2008 Earnings 4Health News:NHP Reports Third Quarter 2008 Earnings 5Health News:NHP Reports Third Quarter 2008 Earnings 6Health News:NHP Reports Third Quarter 2008 Earnings 7Health News:NHP Reports Third Quarter 2008 Earnings 8Health News:NHP Reports Third Quarter 2008 Earnings 9Health News:NHP Reports Third Quarter 2008 Earnings 10Health News:NHP Reports Third Quarter 2008 Earnings 11Health News:NHP Reports Third Quarter 2008 Earnings 12Health News:NHP Reports Third Quarter 2008 Earnings 13Health News:NHP Reports Third Quarter 2008 Earnings 14Health News:NHP Reports Third Quarter 2008 Earnings 15Health News:NHP Reports Third Quarter 2008 Earnings 16Health News:Markel Reports Third Quarter and Nine-Month Results 2Health News:Markel Reports Third Quarter and Nine-Month Results 3Health News:Markel Reports Third Quarter and Nine-Month Results 4Health News:WorldHeart Receives Notice From the NASDAQ Stock Market Regarding Non-Compliance With Marketplace Rule 4310(c)(7) 2Health News: TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China 2
(Date:8/28/2015)... 2015 Research and ... the "Investigation Report on China,s Insulin Aspart ... Developed by Novo Nordisk, insulin aspart (under ... drug for the treatment of diabetes. Compared with ... insulin analog, starts working fast and reports higher ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Novartis, ranibizumab was approved by CFDA ... 2012. Currently, only Lucentis, a product of Novartis, is ... as the first self- developed drug for the treatment ...
(Date:8/28/2015)... 28, 2015  IP Shakti, LLC, today announced that it ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... new corporate identity signifies our transformation into a company focused ... platform for patent claim validity." ... proprietary AIA Shield™ platform, the Company commenced a corporate re-branding ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Investigation Report on China's Ranibizumab Market, 2012-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... study showed effect size of VYVANSE ranged from ... Shire plc (LSE: SHP, Nasdaq:,SHPGY, TSX: SHQ), the ... analysis of VYVANSE(TM) (lisdexamfetamine,dimesylate) effect size. These findings ... in Boston. Effect size is a standardized and,scientific ...
... Open-Label Follow-up Include Longer-term Safety ... ... 26 Adults with Attention Deficit,Hyperactivity Disorder (ADHD) treated with ... management compared to adults taking placebo,according to study results presented ...
Cached Medicine Technology:Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 2Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 3Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 4Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 5New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo 2New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo 3New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo 4
Pefakit in-TDT Calibrators and Controls...
PT-HS with Calcium - 2 ml...
Plasma Control Level 1 - 1 ml...
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
Medicine Products: